Teva and Actavis taken to court over acne drug

16-03-2017

Teva and Actavis taken to court over acne drug

Photo: Courtesy of Teva

Dow Pharmaceutical Sciences and Valeant Pharmaceuticals have sued Teva and its subsidiary Actavis for patent infringement of Onexton (clindamycin phosphate and benzoyl peroxide), a treatment for acne.


Teva, Actavis, Dow, Valeant, patent, ANDA, FDA, Onexton, acne, generics, patent infringement,

LSIPR